ADP-β-S (trisodium)

• Description:

  ADP-β-S (trisodium) is an ADP analog and partial agonist. ADP-β-S (trisodium) induces human platelet aggregation and inhibits PGE1-stimulated adenylate cyclase[1].

• Product Name Alternative:

  Adenosine 5'- (β-thiodiphosphate) (trisodium)

• UNSPSC:

  12352005

• Target:

  PGE synthase

• Related Pathways:

  Immunology/Inflammation

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Smiles:

  O[C@H]1[C@@H](O)[C@H](N2C=NC3=C(N=CN=C32)N)O[C@@H]1COP(OP(O[Na])(S[Na])=O)(O[Na])=O

• Molecular Formula:

  C10H12N5Na3O9P2S

• Molecular Weight:

  509.21

• References & Citations:

  [1]Communi D, et al. Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol. 1999 Nov;128 (6) :1199-206.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported